跳至主要内容
临床试验/CTRI/2025/08/092403
CTRI/2025/08/092403尚未招募不适用

A study of efficacy and predictive factors of oral Spironolactone treatment in Chronic Central Serous Retinopathy.

SMS Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年8月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
TO study predictive factors for positive response to oral spironolactone treatment among cases of chronic CSR.

研究概览

简要总结

It is an observational study being conducted at SMS Medical College and Hospital, at Department of Ophthalmology to evaluate the predictive factors for resolution of edema in the patients of Chronic Central Serous Retinopathy after giving the treatment of Tab Spironolactone for 3 months. All patients diagnosed with chronic CSR will be enrolled and started on Tab Spironolactone 25mg BD for a period of 3 months and will be evaluated for the resolution of edema on OCTA at one week, one month and three months.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patient giving informed written consent.
  • Age group 18 to 50 yrs.
  • Chronic Central Serous Retinopathy.
  • Resolution of edema after treatment of Tab Spironolactone.

排除标准

  • Patients with any other macular pathology.
  • Patients with previous photocoagulation laser within one year.
  • Patients with Injection Anti Vascular Growth Factors within one year.
  • Patients with any contraindication to oral Spironolactone such as kidney or liver disease.
  • Patients already taking Tab Spironolactone for some other cause.

结局指标

主要结局

TO study predictive factors for positive response to oral spironolactone treatment among cases of chronic CSR.

时间窗: 1 week, 1 month, 3 months

次要结局

未报告次要终点

研究者

发起方
SMS Medical College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

NITISHA BAIRWA

Sawai Man Singh Medical College, Jaipur.

研究点 (1)

Loading locations...

相似试验

An observational study to determine the outcome of... | 临床试验